ClinVar Miner

Submissions for variant NM_182961.4(SYNE1):c.4471C>G (p.Gln1491Glu)

gnomAD frequency: 0.00024  dbSNP: rs144276162
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000713664 SCV000344790 uncertain significance not provided 2018-04-13 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000713664 SCV000844291 uncertain significance not provided 2021-03-19 criteria provided, single submitter clinical testing
Invitae RCV000803439 SCV000943310 uncertain significance Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant 2024-01-19 criteria provided, single submitter clinical testing This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 1498 of the SYNE1 protein (p.Gln1498Glu). This variant is present in population databases (rs144276162, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 290269). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002522019 SCV003544832 uncertain significance Inborn genetic diseases 2021-07-14 criteria provided, single submitter clinical testing The c.4492C>G (p.Q1498E) alteration is located in exon 35 (coding exon 34) of the SYNE1 gene. This alteration results from a C to G substitution at nucleotide position 4492, causing the glutamine (Q) at amino acid position 1498 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Revvity Omics, Revvity Omics RCV000713664 SCV003826478 uncertain significance not provided 2019-03-22 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.